Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.
Invasive zygomycosis rarely complicates trauma. We describe the first recorded case of invasive infection of the anterior abdominal wall and omentum with the zygomycete Syncephalastrum racemosum, which was successfully treated with partial surgical debridement and amphotericin B lipid complex.
Schlebusch
Sanmarié
S
Division of Microbiology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane Qld 4102, Australia. Sanmarie_schlebusch@health.qld.gov.au
Looke
David F M
DF
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003646:Debridement; D004338:Drug Combinations; D006801:Humans; D008297:Male; D009090:Mucorales / Q000302:isolation & purification*; D009091:Mucormycosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010715:Phosphatidylglycerols / Q000627:therapeutic use*; D014950:Wounds, Penetrating / Q000150:complications
D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B